Pharmacogenetics of Cancer Therapy: Getting Personal
- 1 July 1998
- journal article
- review article
- Published by Elsevier in American Journal of Human Genetics
- Vol. 63 (1), 11-16
- https://doi.org/10.1086/301941
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Host Susceptibility to Cancer ProgressionAmerican Journal of Human Genetics, 1998
- Nm23-H1: Genetic Alterations and Expression Patterns in Tumor MetastasisAmerican Journal of Human Genetics, 1998
- Genetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanismsPharmacogenetics, 1996
- Diagnostic analysis, clinical importance and molecular basis of dihydropyrimidine dehydrogenase deficiencyTrends in Pharmacological Sciences, 1995
- Beneficial effects of conversion from cyclosporin to azathioprine after kidney transplantationThe Lancet, 1995
- Azathioprine-induced myelosuppression in thiopurine methyltransferase deficient heart transplant recipientThe Lancet, 1993
- Molecular genetics of the N-acetyltransferasesPharmacogenetics, 1993
- Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphocytic leukemiaThe Journal of Pediatrics, 1991
- Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemiaThe Lancet, 1990
- The Purine Path to ChemotherapyScience, 1989